Alan Menter, MD: Dr Menter served on the Advisory Board and was a consultant, investigator, and speaker for Abbott Labs, Amgen, and Centocor, receiving grants and honoraria; served on the Advisory Board and was an investigator and consultant for UCB Pharma, receiving grants and honoraria; was a consultant, investigator and speaker for Warner Chilcott and Wyeth, receiving honoraria; served on the Advisory Board and was an investigator for Galderma and Genentech, receiving grants and honoraria; was a consultant and investigator for Astellas, receiving grants and honoraria; was an investigator for 3M Pharmaceuticals and XOMA, receiving grants and Novo Nordisk, receiving no compensation.
Neil J. Korman, MD, PhD: Dr Korman has served on the Advisory Board and was investigator and speaker for Genentech and Astellas Pharma Inc, receiving grants and honoraria; served on the Advisory Board and was investigator for Centocor, receiving grants and residency/fellowship program funding; was investigator and speaker for Amgen, receiving grants and honoraria; and served on the Advisory Board, was consultant, investigator, and speaker for Abbott Labs, receiving grants and honoraria.
Craig A. Elmets, MD: Dr Elmets has served on the Advisory Board and was investigator for Amgen and Abbott Labs, receiving grants and honoraria; was consultant for Astellas Pharma Inc, receiving honoraria; and was an investigator for Genentech, Centocor, and Connetics, receiving grants.
Steven R. Feldman, MD, PhD: Dr Feldman served on the Advisory Board and was investigator and speaker for Galderma, Stiefel Laboratories, Warner Chilcott, Abbott Labs, and Astellas Pharma Inc, receiving grants and honoraria; served on the Advisory Board for PhotoMedex, receiving stock options; received grants from National Psoriasis Foundation and Dermatology Foundation, CORIA Laboratories, Ltd, Aventis Pharma, American Society of Dermatologic Surgery, Ortho Pharma, and Roche Dermatology; was an investigator and speaker for Amgen, Centocor, and Genentech, receiving grants and honoraria; was a speaker and consultant for Bristol-Myers Squibb Derm and Biogen Idec, receiving grants; and speaker for 3M and Novartis, receiving grants.
Joel M. Gelfand, MD: Dr Gelfand served as consultant and investigator with Amgen, Centocor, Abbott Labs, and Pfizer, receiving grants and honoraria; was consultant with Wyeth, Genentech, Shire Pharmaceuticals, Covance, Celgene, and Luitpold Pharmaceuticals, receiving honoraria; and investigator with Shionogi, receiving grants.
Kenneth B. Gordon, MD: Dr Gordon served on the Advisory Board and was consultant, investigator, and speaker for Abbott Labs and Amgen, receiving grants and honoraria; was investigator for Genentech, receiving grants; and was on the Advisory Board, a consultant and investigator for Centocor, receiving grants and honoraria.
Alice Gottlieb, MD, PhD: Dr Gottlieb served as a speaker, consultant, and was on the Advisory Board for Amgen Inc and Wyeth Pharmaceuticals; has consulting/ advisory board agreements with Beiersdorf, Abbott Labs, Sankyo, Kemia, Actelion, Novo Nordisk, Immune Control, Dermipsor, Can-Fite, Celgene, Centocor, Inc, Bristol-Myers Squibb, Warner Chilcott, Roche, Medarex, Celera, UCB, Almirall, RxClinical, MEDACorp, and Incyte; and has consulted for Magen BioSciences, PureTech, and Teva. She has received grants from Amgen, Wyeth Pharmaceuticals, Immune Control, Celgene, Centocor, Inc, Incyte, and PharmaCare. Almost all income has been paid to her employer directly.
John Y. M. Koo, MD: Dr Koo served on the Advisory Board, was speaker, consultant, and investigator for Amgen, Abbott Labs, Astellas, Warner Chilcott, and Galderma, receiving grants and honoraria; was investigator for Genentech, receiving grants; and was on the Advisory Board, consultant and investigator for Photomedix and Teikoku, receiving no compensation.
Mark Lebwohl, MD: Dr Lebwohl served on the Advisory Board and was speaker for Abbott Labs, Amgen, Astellas, Centocor, Galderma, Genentech, Stiefel, and Warner Chilcott, receiving honoraria; served on the Advisory Board and was consultant and speaker for PharmaDerm, receiving honoraria; was speaker for Novartis and Ranbaxy Laboratories, receiving honoraria; was consultant for Biogen, UCB, DermiPsor, Isotechnika, Sanofi-Aventis, Triax, and York Pharma receiving honoraria; and was on the Advisory Board for Medicis and Pfizer, receiving honoraria Members of Dr Lebwohl's department own patents on short-contact tazarotene, topical genistein, and use of the excimer laser for vitiligo.
Henry W. Lim, MD: Dr Lim is an investigator for Orfagen, receiving grants; a consultant with LaRoche- Posay receiving honoraria; and consultant and investigator with Johnson & Johnson, receiving grants and honoraria. As chairman, Dr. Lim's department's clinical research office participates in many clinical trials, none of which benefit him directly.
Abby S. Van Voorhees, MD: Dr Van Voorhees served on the Advisory Board, was an investigator and speaker for Amgen and Genentech, receiving grants and honoraria; investigator for Astellas, IDEC, and Roche, receiving grants; on the Advisory Board and investigator for Bristol- Myers Squibb and Warner Chilcott, receiving grants and honoraria; on the Advisory Board and speaker for Abbott Labs, Centocor, and Connetics, receiving honoraria; was consultant for Incyte, Xtrac, and VGX Pharmaceuticals, receiving honoraria, and has received honoraria from Synta Pharmaceuticals for another function. Dr Van Voorhees' spouse is an employee with Merck, receiving a salary, stock, and stock options.
Karl R. Beutner, MD, PhD: Chair, Clinical Research Committee. Dr Beutner was an employee of Anacor, receiving salary, stock, and stock options; stockholder of Dow Pharmaceutical Sciences receiving stock.
Reva Bhushan, PhD: Dr Bhushan had no relevant conflicts of interest to disclose.